We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-1.75%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$892M
AUM Growth
+$114M
Cap. Flow
+$142M
Cap. Flow %
15.87%
Top 10 Hldgs %
24.46%
Holding
5,559
New
1,359
Increased
1,658
Reduced
1,483
Closed
897

Sector Composition

Rank Sector Weight
1 Technology 10.09%
2 Healthcare 7.43%
3 Financials 6.65%
4 Consumer Discretionary 5.15%
5 Communication Services 4.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FISI icon
3151
Financial Institutions
FISI
$823M
$6K ﹤0.01%
264
-116
-31% -$2.67K
GEF icon
3152
Greif
GEF
$4.97B
$6K ﹤0.01%
130
-1,229
-90% -$61.4K
HNRG icon
3153
Hallador Energy
HNRG
$762M
$6K ﹤0.01%
466
-3,288
-88% -$42.2K
HPI
3154
John Hancock Preferred Income Fund
HPI
$431M
$6K ﹤0.01%
+303
New +$6.09K
IAE
3155
Voya Asia Pacific High Dividend Equity Income Fund
IAE
$95M
$6K ﹤0.01%
+442
New +$5.91K
ISHG icon
3156
iShares 1-3 Year International Treasury Bond ETF
ISHG
$828M
$6K ﹤0.01%
65
+26
+67% +$2.43K
JBLU icon
3157
JetBlue
JBLU
$2.13B
$6K ﹤0.01%
+600
New +$6.85K
KZIA
3158
Kazia Therapeutics
KZIA
$154M
$6K ﹤0.01%
11
MTW icon
3159
Manitowoc
MTW
$746M
$6K ﹤0.01%
296
+170
+135% +$4.43K
NERV icon
3160
Minerva Neurosciences
NERV
$219M
$6K ﹤0.01%
+129
New +$6.86K
NUWE icon
3161
Nuwellis
NUWE
$477K
0
OHI icon
3162
Omega Healthcare
OHI
$14.1B
$6K ﹤0.01%
178
-5,925
-97% -$218K
PACB icon
3163
Pacific Biosciences
PACB
$357M
$6K ﹤0.01%
1,148
+453
+65% +$2.37K
PCH
3164
DELISTED
PotlatchDeltic
PCH
$6K ﹤0.01%
151
-162
-52% -$6.76K
PHYS icon
3165
Sprott Physical Gold
PHYS
$15.8B
$6K ﹤0.01%
600
PLX icon
3166
Protalix BioTherapeutics
PLX
$179M
$6K ﹤0.01%
246
-21
-8% -$605
POR icon
3167
Portland General Electric
POR
$5.97B
$6K ﹤0.01%
+178
New +$5.91K
PSO icon
3168
Pearson
PSO
$9.72B
$6K ﹤0.01%
+312
New +$5.95K
QUIK icon
3169
QuickLogic
QUIK
$234M
$6K ﹤0.01%
144
-1,794
-93% -$93.7K
RCON icon
3170
Recon Technology
RCON
$2.32M
$6K ﹤0.01%
+13
New +$5.05K
RIOT icon
3171
Riot Platforms
RIOT
$7.14B
$6K ﹤0.01%
443
+141
+47% +$2.09K
RRX icon
3172
Regal Rexnord
RRX
$11.7B
$6K ﹤0.01%
100
-5,502
-98% -$396K
SABR icon
3173
Sabre
SABR
$900M
$6K ﹤0.01%
312
-14,846
-98% -$280K
SB icon
3174
Safe Bulkers
SB
$789M
$6K ﹤0.01%
936
-16,861
-95% -$136K
SCI icon
3175
Service Corp International
SCI
$11.5B
$6K ﹤0.01%
300
-2,964
-91% -$63.2K

Similar funds

Tower Research Capital (TRC)'s Q3 2014 Portfolio in Review

As of Q3 2014, Tower Research Capital (TRC) held 5,559 positions worth $892M, up 15% from $778M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Tower Research Capital (TRC) deployed $142M of net new capital in Q3 2014, opening 1,359 new positions and adding to 1,658 existing holdings. Its largest new stake was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 35,647 shares worth $9.81M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 5.5% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $106M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2014 buy was State Street SPDR S&P Oil & Gas Exploration & Production ETF: 35,647 shares worth $9.81M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q3 2014, an estimated $23.8M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $106M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Value ETF in Q3 2014, selling an estimated $9.03M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 24% of its $892M portfolio in Q3 2014.
  • Tower Research Capital (TRC) opened 1,359 new positions and closed 897 in Q3 2014.
  • Tower Research Capital (TRC)'s portfolio value rose 15% quarter-over-quarter to $892M.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2014, filed 31 Oct 2014.